ArticleScience translational medicine2016

Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression.

Kol Jia Yong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.